A Study to Evaluate Advanced Ultrasound Techniques for Diagnosis of Giant Cell Arteritis
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 19-008794
Sponsor Protocol Number: 19-008794
About this study
The purpose of this study is to find out if advanced ultrasound studies can be used to make a diagnosis of giant cell arteritis. Ultimately, we hope to be able to offer non-invasive diagnostic options as an alternative to biopsy to future patients who are being evaluated for giant cell arteritis.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria:
- Adult male and non-pregnant women 18 years old or older.
- Subject has suspected temporal arteritis.
- Subject is scheduled for TAB based on clinical diagnostic protocol.
- Subject is able to understand the study procedure and provide informed consent.
Exclusion Criteria:
- Subject has an established prior diagnosis of temporal arteritis/giant cell arteritis.
- Subject is pregnant or breast feeding.
- Subject is unable to provide informed consent.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
|
Rochester, Minn.
Mayo Clinic principal investigator Lilly Wagner, M.D. |
Closed for enrollment |
|
More information
Publications
Publications are currently not available